|Articles|March 1, 2003

March 2003
Volume 9
Issue 3

Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Author(s)Jonathan B. Brown, PhD, MPP, Gregory A. Nichols, PhD

Download PDF: Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Articles in this issue

almost 23 years ago

Article

How Do Minor Changes in the Definition of Blood Pressure Control Affect the Reported Success of Hypertension Treatment?

almost 23 years ago

Article

Physician Attitudes Toward Strategies to Promote the Adoption of Medical Evidence Into Clinical Practice

almost 23 years ago

Article

Patient Reports of Coverage Denial: Association With Ratings of Health Plan Quality and Trust in Physician

almost 23 years ago

Article

Restoring Trust to Managed Care, Part 2: A Focus on Physicians

almost 23 years ago

Article

Review of the Newer Antiepileptic Drugs

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

Prior Authorization Ranked Top Barrier to Health Care Access After Cost

Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024

Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM

FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film

Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL